H-G Klingemann

Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors

SR Jackson, MG Tweeddale, MJ Barnett et al. · Bone Marrow Transplantation · 1998 · 140 citations

Medicine, Hematology, Internal Medicine +16

Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience

INM Micallef, Mukesh Chhanabhai, RD Gascoyne et al. · Bone Marrow Transplantation · 1998 · 111 citations

Medicine, Hematology, Immunology +15

Natural killer cell-based immunotherapeutic strategies

H-G Klingemann · Cytotherapy · 2005 · 71 citations

Life Sciences, Immunology, Oncology +12

Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin’s disease

DE Reece, TJ Nevill, Antoine Sayegh et al. · Bone Marrow Transplantation · 1999 · 33 citations

Medicine, Oncology, Pharmacology +16

Induction of sensitivity to NK-mediated cytotoxicity by TNF-α treatment: possible role of ICAM-3 and CD44

Guitta Maki, Gerald Krystal, G J Dougherty et al. · Leukemia · 1998 · 26 citations

Life Sciences, Immunology, Cancer Immunology +8